Characterization of purified tumor infiltrating T cells, associated with reduction of pro-tumor PD-L1 and VEGF gene transcription, improved T cell responses and reduce pro-tumor biomarker gene transcription [29]. The gene discussed is CD274; the disease is neoplasm.